Human Resources
Talent acquisition and retention: The current state of play in biopharma and medtech sectors
Human Resources: Evolving employer and employee preferences are significantly influencing talent acquisition and retention outcomes.
Maree Paras, Associate Director, Paras and Partners and Vanessa Meikle, Founder & CEO, Hunton Executive joined Health Industry Hub to deep dive into the current state of talent acquisition and retention across the pharma, medtech and biotech sectors, including “The great resignation or the great rethink?”
According to recent Gartner data, 30% of the skills that were present in job descriptions three years ago will be obsolete in 2022. Vanessa and Maree shared their views on the top workforce skills (soft and hard skills) that are critical in the current ecosystem and the importance of employee investment and commitment in lifelong learning to fulfil what employers define as the “ideal candidate”.
Finally, the duo considered the biggest changes and movements in the current workforce and how this will be evolving in the next 6 months.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreNews & Trends - Pharmaceuticals
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More